D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
VTYX holding history
Ventyx Biosciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VTYX overviewAll 13F holders of VTYXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −1,665,474−100.0% | Sold out | Holders |
| Q4 2025 | 1,665,474 | $15.0M | <0.1% | +1,142,786+218.6% | Added | Holders |
| Q3 2025 | 522,688 | $1.63M | <0.1% | +473,756+968.2% | Added | Holders |
| Q2 2025 | 48,932 | $104.7K | <0.1% | −17,261−26.1% | Reduced | Holders |
| Q1 2025 | 66,193 | $76.1K | <0.1% | +13,962+26.7% | Added | Holders |
| Q4 2024 | 52,231 | $114.4K | <0.1% | −54,437−51.0% | Reduced | Holders |
| Q3 2024 | 106,668 | $232.5K | <0.1% | +17,288+19.3% | Added | Holders |
| Q2 2024 | 89,380 | $206.5K | <0.1% | −106,734−54.4% | Reduced | Holders |
| Q1 2024 | 196,114 | $1.08M | <0.1% | −318,505−61.9% | Reduced | Holders |
| Q4 2023 | 514,619 | $1.27M | <0.1% | +514,619 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −47,112−100.0% | Sold out | Holders |
| Q2 2023 | 47,112 | $1.55M | <0.1% | −24,747−34.4% | Reduced | Holders |
| Q1 2023 | 71,859 | $2.41M | <0.1% | −16,500−18.7% | Reduced | Holders |
| Q4 2022 | 88,359 | $2.90M | <0.1% | −84,371−48.8% | Reduced | Holders |
| Q3 2022 | 172,730 | $6.03M | <0.1% | +154,787+862.7% | Added | Holders |
| Q2 2022 | 17,943 | $219.0K | <0.1% | +17,943 | New | Holders |